OXO Chefs in Residence Chefs Danielle Sepsy and Fariyal Abdullahi OXO Chefs in Residence Chefs Danielle Sepsy and Fariyal Abdullahi Now entering its fifth year, the OXO Chefs in Residence program continues to evolve with a renewed focus on emotional storytelling and globally inspired cooking. This year's theme, Cook the Mood, taps into the deep connection people have with food, exploring feelings that range from nostalgia and pride to joy and comfort. Cook the Mood transforms everyday meals into meaningful ...

Alibaba Group Holding BABA posted better-than-expected revenue for the first quarter on Friday.The company posted quarterly revenue of $34.57 billion, up 2% year-over-year, surpassing the consensus estimate of $34.26 billion. On a like-for-like basis, excluding revenue from the divested Sun Art and Intime businesses, Alibaba’s revenue would have grown 10% year-over-year.Despite the top-line beat, adjusted earnings per American Depositary Share (ADS) came in at $2.06, falling short of the analyst consensus o ...

An Activision Blizzard's Call of Duty: Modern Warfare video game is inserted into Microsoft's Xbox One video game console.Call of Duty, one of the most successful video game franchises of all time, will be coming to the big screen with the help of Paramount.The studio announced Tuesday that it had inked a deal with Microsoft-owned Activision to develop, produce and distribute a live-action feature film based on the first-person shooter game."As a lifelong fan of Call of Duty this is truly a dream come true, ...

One company that I continue to believe offers attractive upside is grocery chain The Kroger Co. (NYSE: KR ). But recently, the performance of the business has been disappointing. With bottom-line results worsening, shares have also lagged the broader market, climbing only 3.2% since ICrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers ...

Group 1 - Nio Inc's stock has decreased by 2.4%, trading at $6.24, following a second-quarter earnings and revenue miss despite record monthly sales and deliveries [1] - The stock is on track for its third loss in four sessions but has a year-over-year gain of 43.6%, currently pulling back from a year-to-date peak of $6.83 [2] - The stock remains above all short- and long-term moving averages, with support around the $6 level [2] Group 2 - Today's options activity shows 139,000 calls and 73,000 puts traded, which is double the typical volume for this time [3] - The most popular options contract is the weekly 9/5 6-strike put, followed by the 6.50-call in the same series [3] - Short-term options traders are favoring puts, with NIO's put/call open interest ratio in the 82nd percentile of annual readings [4] Group 3 - Short interest has increased by 5.4% in the last two reporting periods, now accounting for 10.3% of the equity's available float [4]

Core Insights - Orion Energy Systems, Inc. is expanding its Voltrek division to the Southeastern United States in response to increasing demand for EV charging and electrical infrastructure solutions [1][2] - The new office in Jacksonville, Florida, will be led by William B. Rigsby, who has a strong background in sales growth within the EV charging industry [2][3] - The expansion aligns with federal guidance on the allocation of $5 billion in public funds for EV charging infrastructure, with 84% of the funds yet to be allocated [4] Company Expansion - The Jacksonville office marks the third regional expansion for Orion/Voltrek, following its existing facilities in Lawrence, MA, and Manitowoc, WI [2] - The initiative demonstrates Orion/Voltrek's commitment to being present where customers are located, enhancing their service capabilities [5] Leadership and Expertise - William Rigsby brings over 15 years of experience in the EV charging sector, having previously served as Vice President of Sales Operations at NovaCHARGE, Inc. [3] - His leadership is expected to drive significant sales growth and market expansion for the Voltrek division in the Southeast [3][4] Market Context - The expansion is in line with a broader market trend where decision-making regarding EV charging infrastructure is increasingly shifting to state-level authorities [5] - Orion's Voltrek division is well-positioned to meet the evolving needs of the market, particularly with the federal emphasis on reliable charging infrastructure [4][5]

Group 1 - CGI Group, Inc. (GIB) is experiencing significant activity in the options market, particularly with the Nov 21, 2025 $75.00 Put showing high implied volatility, indicating potential for a major price movement [1] - Implied volatility reflects market expectations for future stock movement, suggesting that investors anticipate a significant event that could lead to a rally or sell-off [2] - CGI Group currently holds a Zacks Rank 4 (Sell) in the Computer-Services Industry, which is in the top 40% of the Zacks Industry Rank, with recent analyst estimates for the current quarter slightly increasing from $1.52 to $1.53 per share [3] Group 2 - The high implied volatility surrounding CGI Group may indicate a developing trading opportunity, as options traders often seek to sell premium on such options to capture decay [4]

Core Insights - Corcept Therapeutics' sole-marketed drug, Korlym, has shown strong sales performance, with $351.6 million in sales for the first half of 2025, reflecting a year-over-year increase of approximately 13.2% [1][9] - The company anticipates full-year 2025 Korlym sales to reach $857.1 million, indicating a nearly 27% increase year-over-year [1][3] - Management expects a significant rise in Korlym prescriptions in the second half of 2025 as vendor issues are resolved [2][3] Sales and Revenue Expectations - Korlym sales were impacted by vendor capacity issues in Q1 2025 but improved in Q2, with expectations for continued growth in H2 2025 [2][3] - Corcept projects total revenues for 2025 to be between $850 million and $900 million [3] Pipeline Developments - Corcept is developing relacorilant for Cushing's syndrome, with a new drug application submitted to the FDA, and a decision expected by December 30, 2025 [4][9] - Approval of relacorilant is anticipated to broaden the patient base and reduce reliance on Korlym for future growth [5] Additional Indications and Studies - The company is also pursuing relacorilant for other indications, including a combination therapy for platinum-resistant ovarian cancer and adrenal cancer [6][7] - The BELLA study is evaluating the efficacy of relacorilant combined with nab-paclitaxel and Avastin for ovarian cancer treatment [7] Market Performance and Valuation - Corcept's stock has increased by 38.3% year-to-date, outperforming the industry average of 8.3% [8] - The company's shares are trading at a premium, with a price-to-sales ratio of 11.73 compared to the industry average of 2.38 [10] Earnings Estimates - The Zacks Consensus Estimate for 2025 earnings per share has decreased from $1.39 to $1.15, and for 2026, it has decreased from $2.08 to $1.71 [11]

Group 1: Sportradar Group - Sportradar Group is a provider of sports betting and sports entertainment products and services, holding a Zacks Rank 1 (Strong Buy) [1] - The Zacks Consensus Estimate for Sportradar's current year earnings has increased by 41.9% over the last 60 days [1] - The company's shares gained 28.9% over the last three months, outperforming the S&P 500's gain of 8.8%, and it possesses a Momentum Score of A [2] Group 2: Dorman Products - Dorman Products is a leading supplier of Dealer Exclusive replacement parts to the Automotive, Medium and Heavy-Duty Aftermarkets, also holding a Zacks Rank 1 [2] - The Zacks Consensus Estimate for Dorman's current year earnings has increased by 7.7% over the last 60 days [2] - Dorman's shares gained 28.2% over the last three months, again outperforming the S&P 500's gain of 8.8%, and it possesses a Momentum Score of A [3] Group 3: SB Financial Group - SB Financial Group is a financial services holding company offering a full range of financial services for consumers and small businesses, with a Zacks Rank 1 [4] - The Zacks Consensus Estimate for SB Financial's current year earnings has increased by 9.9% over the last 60 days [4] - The company's shares gained 11% over the last three months, compared to the S&P 500's gain of 8.8%, and it possesses a Momentum Score of A [5]

Core Viewpoint - The market anticipates a year-over-year decline in earnings for Dave & Buster's despite an increase in revenues, with actual results being crucial for stock price movement [1][3]. Earnings Expectations - Dave & Buster's is expected to report quarterly earnings of $0.88 per share, reflecting a decline of 21.4% year-over-year, while revenues are projected to be $564.4 million, an increase of 1.3% from the previous year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 4.62% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Most Accurate Estimate for Dave & Buster's is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +3.41%, suggesting a likelihood of beating the consensus EPS estimate [12]. Historical Performance - In the last reported quarter, Dave & Buster's had an expected EPS of $0.96 but reported $0.76, resulting in a surprise of -20.83%. Over the last four quarters, the company has beaten consensus EPS estimates twice [13][14]. Investment Considerations - While a potential earnings beat may influence stock movement, other factors can also affect investor sentiment, making it essential to consider the broader context [15][17].